Nanoparticulate Drug Delivery to the Retina
The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Retinal diseases, such as age-related macular degeneration and diabetic retinopathy, are the leading causes of blindness worldwide. The mainstay of treatment for these blinding diseases remains to be surgery, and the available pharmaceutical therapies on the market are limited, partially owing to various biological barriers in hindering the delivery of therapeutics to the retina. The nanoparticulate drug delivery system confers the capability for delivering therapeutics to the specific ocular targets and, hence, potentially revolutionizes the current treatment landscape of retinal diseases. While the research to date indicates the enormous therapeutics potentials of the nanoparticulate delivery systems, the successful translation of these systems from the bench to bedside is challenging and requires a combined understanding of retinal pathology, physiology of the eye, and particle and formulation designs of nanoparticles. To this end, the review begins with an overview of the most prevalent retinal diseases and related pharmacotherapy. Highlights of the current challenges encountered in ocular drug delivery for each administration route are provided, followed by critical appraisal of various nanoparticulate drug delivery systems for the retinal diseases, including their formulation designs, therapeutic merits, limitations, and future direction. It is believed that a greater understanding of the nano-biointeraction in eyes will lead to the development of more sophisticated dru…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
International Journal of Ophthalmology
(2020) · International Journal of Ophthalmology · doi:10.18240/ijo · Cited by 597
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
Pastor, J. C., Rojas, J., Pastor-Idoate, S., Di Lauro, S., Gonzalez-Buendia, L., & Delgado-Tirado, S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.005 · Cited by 344
Drug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 326
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Research works printed but not linked: 9
- 10.18043/ncm.78.2.124 · DOI
- Moraru A. D., 2014, Rom j Morphol Embryol., 55, 869
- Spitznas M., 1974, Adv. Ophthalmol., 28, 78
- Bochot A., 2002, Invest Ophthalmol Vis Sci., 43, 253
- Fiscella R., 1987, Can. J. Ophthalmol., 22, 307
- Rahman M., 2012, Polyester
- 10.1016/j.jconrel.2012.12.005 · DOI · Paper page
- Su D. H., 2006, Invest. Ophthalmol. Vis. Sci., 47, 5122
- Cai X., 2016, Mol. Vis., 22, 1176
Cited by
Nguyen, D. D., Luo, L.-J., Yang, C.-J., & Lai, J.-Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c05824 · Cited by 213
Nanoparticles in ocular applications and their potential toxicity
Cao, Y., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., Li, M., & Xu, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.931759 · Cited by 119
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
Jiang, H., & Xu, Z. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2204206 · Cited by 68
“Due to their splendid stability and wide drug loading range, micelles modified with HA have been widely investigated for tumor therapy (W. Li et al., 2020; Zhang, Ren et al., 2020; Yan, Feng et al., 2022).”
BackgroundGreen Light‐Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma
Long, K., Yang, Y., Lv, W., Jiang, K., Li, Y., Lo, A., Lam, W., Zhan, C., & Wang, W. (2021) · Advanced Science · doi:10.1002/advs.202101754 · Cited by 63
Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery
Batur, E., Özdemir, S., Durgun, M. E., & Özsoy, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17040511 · Cited by 64
“These obstacles need to be cleared before liposomes are applied topically [39].”
BackgroundInfluential
Metadata
- Authors
- Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F.
- Affiliations
- Xi'an Jiaotong University (CN)
- University of Hong Kong (HK)
- Aptorum Group Limited, Unit 232, 12 Science Park West Avenue, Hong Kong Science Park, Shatin New Town, Hong Kong
- Corresponding author
- Chow, Shing Fung
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-08
- Volume
- 18
- Issue
- 2
- Pages
- 506-521
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W3033428304
- Cited by
- 59
- References
- 153
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 12 · 2022: 9 · 2021: 8
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Hong Kong (202007002)
- Natural Science Foundation of Shaanxi Province (2020JQ-093)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- nanoparticle drug delivery, retinal drug delivery, ocular drug delivery, age-related macular degeneration, diabetic retinopathy, retinal disease, ocular barriers, translation to clinical practice
- MeSH terms
- Administration, Oral, Animals, Blindness, Blood-Retinal Barrier, Choroid, Conjunctiva, Cornea, Disease Models, Animal, Humans, Ophthalmic Solutions, Permeability, Retina, Retinal Diseases, Sclera, Nanoparticles, Administration, Ophthalmic, Administration, Intravenous, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanoparticulate Drug Delivery to the Retina. https://app.cochat.ai/papers/10.1021/acs.molpharmaceut.0c00224
- The paper
- Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F. (2021). Nanoparticulate Drug Delivery to the Retina. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.0c00224
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.